(-0.66%) 5 073.75 points
(-0.21%) 38 599 points
(-1.20%) 17 452 points
(0.10%) $82.89
(-0.24%) $1.649
(-0.46%) $2 327.60
(-0.79%) $27.13
(-0.60%) $910.30
(-0.10%) $0.934
(-0.05%) $10.98
(-0.04%) $0.802
(-0.02%) $92.30
Live Chart Being Loaded With Signals
China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese medicines in the People's Republic of China and Hong Kong...
Stats | |
---|---|
Today's Volume | 398 000 |
Average Volume | 748 338 |
Market Cap | 6.81B |
EPS | HKD0 ( 2024-03-28 ) |
Last Dividend | HKD0.353 ( 2023-04-28 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | 6.75 |
ATR14 | HKD0.0210 (0.22%) |
Volume Correlation
China Shineway Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
China Shineway Correlation - Currency/Commodity
China Shineway Financials
Annual | 2023 |
Revenue: | HKD4.52B |
Gross Profit: | HKD3.39B (75.15 %) |
EPS: | HKD1.280 |
Q2 | 2023 |
Revenue: | HKD2.40B |
Gross Profit: | HKD1.80B (75.21 %) |
EPS: | HKD0.650 |
Q4 | 2022 |
Revenue: | HKD2.14B |
Gross Profit: | HKD1.61B (75.56 %) |
EPS: | HKD0.520 |
Q2 | 2022 |
Revenue: | HKD1.82B |
Gross Profit: | HKD1.32B (72.98 %) |
EPS: | HKD0.440 |
Financial Reports:
No articles found.
China Shineway Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0.125 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0.353 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.100 | 2005-09-01 |
Last Dividend | HKD0.353 | 2023-04-28 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 36 | -- |
Total Paid Out | HKD5.15 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.84 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 5.37 | |
Div. Directional Score | 8.26 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
3339.HK | Ex Dividend Junior | 2023-05-30 | Annually | 0 | 0.00% | |
1579.HK | Ex Dividend Knight | 2023-05-22 | Annually | 0 | 0.00% | |
0609.HK | Ex Dividend Junior | 2023-10-03 | Annually | 0 | 0.00% | |
9869.HK | Ex Dividend Junior | 2023-09-19 | Insufficient data to determine frequency | 0 | 0.00% | |
2156.HK | Ex Dividend Junior | 2023-06-01 | Annually | 0 | 0.00% | |
1157.HK | Ex Dividend Junior | 2023-07-03 | Annually | 0 | 0.00% | |
0237.HK | Ex Dividend Junior | 2023-08-24 | Semi-Annually | 0 | 0.00% | |
3838.HK | Ex Dividend Junior | 2023-06-12 | Annually | 0 | 0.00% | |
1729.HK | Ex Dividend Junior | 2023-08-30 | Semi-Annually | 0 | 0.00% | |
0762.HK | Ex Dividend Junior | 2023-09-04 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.215 | 1.500 | 5.71 | 8.56 | [0 - 0.5] |
returnOnAssetsTTM | 0.101 | 1.200 | 6.62 | 7.95 | [0 - 0.3] |
returnOnEquityTTM | 0.142 | 1.500 | 9.54 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.242 | -1.000 | 7.58 | -7.58 | [0 - 1] |
currentRatioTTM | 3.35 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 2.95 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 2.42 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0314 | -1.500 | 9.48 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 0 | 1.000 | -1.111 | -1.111 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.424 | 2.00 | 9.86 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.359 | 2.00 | 9.82 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0427 | -1.500 | 9.83 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.751 | 1.000 | 0.809 | 0.809 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.215 | 1.000 | 7.70 | 7.70 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 1.070 | 1.000 | 5.17 | 5.17 | [0.2 - 2] |
assetTurnoverTTM | 0.472 | 0.800 | -0.188 | -0.151 | [0.5 - 2] |
Total Score | 11.15 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 6.74 | 1.000 | 9.42 | 0 | [1 - 100] |
returnOnEquityTTM | 0.142 | 2.50 | 9.70 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.359 | 2.00 | 9.88 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 5.47 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.424 | 2.00 | 9.86 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.242 | 1.500 | 7.58 | -7.58 | [0 - 1] |
pegRatioTTM | 0 | 1.500 | -3.33 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0712 | 1.000 | -0.721 | 0 | [0.1 - 0.5] |
Total Score | 5.37 |
China Shineway
China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese medicines in the People's Republic of China and Hong Kong. The company offers modern Chinese medicines in the form of soft capsules, granules, and injections, as well as TCM Formula Granules in various therapeutic areas, including cardio-cerebrovascular, anti-viral, orthopedics, pediatrics, gynecology, and gastroenterology. It also trades in agricultural products. The company was incorporated in 2004 and is headquartered in Shijiazhuang, the People's Republic of China. China Shineway Pharmaceutical Group Limited is a subsidiary of Forway Investment Limited.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators